We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Five Advances in Fragment-Based Drug Discovery

Five Advances in Fragment-Based Drug Discovery content piece image

Fragment-based drug discovery (FBDD) involves screening a small collection of very small compounds against a target molecule, and then optimizing and linking fragment “hits” to create high-affinity ligands for further development. FBDD forms the basis of many of today’s drug discovery programs because it requires smaller compound libraries, is likely to generate a higher number of hits than traditional high-throughput screening and fragments have been used successfully as a starting point for several approved drugs.

Download this listicle to discover recent advancements in fragment-based screening including:

  • Fragment tailoring
  • Affinity mass spectrometry-based fragment screening
  • Computational approaches using fragments